期刊文献+

核苷酸结合的寡聚结构域2激动剂与Toll样受体激动剂协同诱导血管平滑肌细胞合成促炎症细胞因子 被引量:1

Synergistic Effect of Nucleotide binding Oligomerization Domain 2 and Toll-like Receptor Agonists on Proliferation and Release of Proinflammatory Cytokines in Vascular Smooth Muscle Cells
在线阅读 下载PDF
导出
摘要 目的研究细胞内模式识别受体核苷酸结合的寡聚结构域(NOD)2受体在血管平滑肌细胞中的表达及其诱导血管平滑肌细胞产生促炎症细胞因子过程中的作用,并探讨它与Toll样受体(TLR)2、4在此过程中的相互关系。方法体外培养人冠状动脉血管平滑肌细胞,用NOD2激动剂胞壁酰二肽(MDP)、TLR2激动剂(PAM3)和TLR4激动剂脂多糖(LPS)单独或联合进行刺激,用实时定量逆转录聚合酶链反应检测血管平滑肌细胞中NOD2和成纤维生长因子2mRNA的表达,用酶联免疫吸附法测定细胞培养物上清液中白介素8和肿瘤坏死因子α的浓度,用四甲基偶氮唑盐微量酶反应比色法检测血管平滑肌细胞增殖活性。结果MDP能使血管平滑肌细胞中NOD2mRNA的表达呈时间依赖性上调[0h:(0.028±0.001);3h:(0.045±0.002);6h:(0.053±0.002);24h:(0.162±0.013)],并能引起血管平滑肌细胞中成纤维生长因子2mRNA的表达增加[MDP组:(9.3±0.4)vs对照组:(7.4±0.2);P<0.05],细胞培养物上清液中白介素8[MDP组:(2.4±0.2)μg/Lvs对照组:(1.0±0.1)μg/L;P<0.05]和肿瘤坏死因子α[MDP组:(51.9±4.7)ng/Lvs对照组:(29.4±3.7)ng/L;P<0.05]的分泌增多和细胞增殖活性增加[(0.90±0.05vs对照组:0.72±0.02;P<0.05]。MDP还能协同LPS、PAM3诱导血管平滑肌细胞增殖活性增加,细胞培养物上清液中白介素8和肿瘤坏死因子α的分泌增加。结论NOD2使血管平滑肌细胞增殖活性增加,诱导其分泌促炎症细胞因子。NOD2与TLR2、4在促进血管平滑肌细胞增殖活性增加,诱导血管平滑肌细胞分泌促炎症细胞因子的过程中具有协同作用。 Objective To investigate the expression of nucleotide-binding oligomerization domain 2 (NOD2), an intracelluar pathogen pattern recognition receptor, and Toll like receptor (TLR) 2, 4 in human vascular smooth muscle cells (VSMC), and its effect on production of proinflammatory cytokines in VSMC. Methods Human coronary artery smooth muscle cells were in vitro stimulated with NOD2 agonist Muramyl dipeptide (MDP), TLR2 agonist Pam3CSK4(PAM3)and TLR4 agonist lipopolysaccharides (LPS) alone or MDP in cocultured with either PAM3 or LPS. The mRNA expression of NOD2 and fibroblast growth factor-2(FGF-2) were measured by real time RT-PCR. The concentration in the culture supernatants of interleukin-8(IL-8) and tumor necrosis factor-α (TNF-α) was determined by ELISA. VSMC proliferation was analyzed by the MTT assay. Results MDP up-regulate the expression of NOD2 mRNA in VSMC in a time-dependent manner (0 h:0. 028± 0.001; 3h: 0. 045±0. 002; 6h: 0. 053±0. 002; 24h: 0. 162±0.013). It up-regulate the expression of FGF-2 mRNA (MDP 9. 3±0. 4 vs control 7.4±0. 2; P〈0. 05) in VSMC, induce the production of IL-8(MDP 2.4±0. 2 vs control 1.02±0. 13 μg/L) and TNF-α(MDP 51.9±4. 7 vs control 29.4±3.73 ng/L; respectively, P〈0. 05) increases the proliferation of VSMC (MDP 0. 87±0. 05 vs control 0. 72±0.02, P〈0. 05). Additionally, MDP cocultured with LPS and PAM3 synergetically increase the proliferation of VSMC and the production of IL-8 and TNF-α. Conclusion The activation of NOD2 increase the proliferation of VSMC and the production of proin-flammatory cytokines in VSMC. NOD2 and TLR2 and TLR4 synergetically enhanced these effect.
作者 丁彦春 曲鹏
出处 《中华高血压杂志》 CAS CSCD 北大核心 2007年第12期1017-1021,共5页 Chinese Journal of Hypertension
关键词 血管平滑肌细胞 TOLL样受体2 TOLL样受体4 核苷酸结合的寡聚结构域2 先天免疫 Vascular smooth muscle cell Toll like receptor 2 Toll like receptor 4 Nucleotide-binding oligomerization domain 2 Innate immune
  • 相关文献

参考文献15

  • 1[1]Kufer TA,Banks DJ,Philpott DJ.Innate immune sensing of microbes by Nod proteins[J].Ann N Y Acad Sci,2006,1072:19-27.
  • 2[2]Uematsu S,Akira S.Toll-like receptors and innate immunity[J].J Mol Med,2006,84:712-725.
  • 3和亚萍,曲鹏,李桂华.Toll样受体在Goldblatt鼠左室心肌中的表达-炎症与左心室肥厚相关的一个证据[J].高血压杂志,2005,13(8):483-487. 被引量:16
  • 4王纪文,曲鹏,姜华,王虹艳,李桂华,和亚萍,富晶,吕申.抑制NF-κB对Toll样受体4在Goldblatt鼠左室心肌中表达的影响[J].高血压杂志,2005,13(7):427-431. 被引量:11
  • 5王虹艳,曲鹏,富晶,姜华.TLR4激动上调内皮细胞氧化低密度脂蛋白受体LOX-1表达[J].高血压杂志,2005,13(7):422-426. 被引量:10
  • 6许柳青,叶琼,吴可贵.P38MAPK与血管重构[J].高血压杂志,2005,13(5):262-265. 被引量:3
  • 7[7]Inohara,Chamaillard,McDonald C,et al.NOD-LRR proteins:role in host-microbial interactions and inflammatory disease[J].Annu Rev Biochem,2005,74:355-383.
  • 8[8]Watanabe T,Kitani A,Murray PJ,et al.NOD2 is a negative regulator of toll-like receptor 2-mediated T helper type 1 responses[J].Nature Immunology,2004,5,800-808.
  • 9[9]Uehara A,Yang S,Fujimoto Y,et al.Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2-and NOD1-dependent manner,respectively,in human monocytic cells in culture[J].Cell Micorbiology,2005,7,53-61.
  • 10[10]Fritz J,Girardin SE,Fitting G,et al.Synergistic sitmulation of human monocytes and dendritic cells by toll-like receptor and NOD-1 and NOD-2 activating agonists[J].Eur J Immunol,2005,35,2459-2470.

二级参考文献56

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1370
  • 2Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity[J]. Nature, 1997,388: 394-397.
  • 3Frantz S, Kobzik L, Kim YD. Toll 4 (TLR4) expression in cardiac myocytes in normal and failing myocardium[J]. J Clin Invest, 1999,104: 271-280.
  • 4Guolong Z, Ghosh S. Toll-like receptor-mediated NFκB activation: a phylogenetically conserved paradigm in innate immunity [J]. J Clin Invest, 2001,107: 13-19.
  • 5Luft FC, Mervaala E, Müller DN, et al. Hypertension-Induced end-organ damage a new transgenic approach to an old problem [J]. Hypertension, 1999,33: 212-218.
  • 6Mervaala E, Muller DN, Schmidt F, et al. Blood pressure-independent effects in rats with human rennin and angiotensinogen genes[J]. Hypertension, 2000,35: 587-594.
  • 7Haller H, Behrend M, Park JK, et al. Monocyte infiltration and c-fms expression in hearts of spontaneously hypertensive rats[J]. Hypertension, 1995,25:132-138.
  • 8Mervaala E, Muller DN, Park JK, et al. Cyclosporin a protects against angiotensin Ⅱ induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes[J]. Hypertension, 2000,35: 360-366.
  • 9Muller DN, Dechend R, Mervaala EMA, et al. NFκB inhibition ameliorates angiotensin Ⅱ induced inflammatory damage in rats[J]. Hypertension, 2000,35 : 193-201.
  • 10Shoham S, Huang C, Chen JM, et al. Toll-Like receptor 4 mediates intracellular signaling without TNF-α release in response to cryptococcus neoformans polysaccharide capsule [J]. The journal of immunology, 2001,166 : 4620-4626.

共引文献35

同被引文献27

  • 1王虹艳,曲鹏,富晶,姜华.TLR4激动上调内皮细胞氧化低密度脂蛋白受体LOX-1表达[J].高血压杂志,2005,13(7):422-426. 被引量:10
  • 2王虹艳,曲鹏,吕申,刘敏,姜华.Toll样受体4/核因子κB和氧化低密度脂蛋白受体LOX-1对单核内皮细胞黏附的影响[J].中华心血管病杂志,2005,33(9):827-831. 被引量:15
  • 3马林,丁彦春,崔晓琼,姜华,王虹艳,曲鹏.Toll样受体4—核因子κB信号通路在血管成形术后再狭窄过程中的作用[J].中国动脉硬化杂志,2006,14(7):596-600. 被引量:6
  • 4Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity[ J]. Cell, 2006, 124(4) : 783-801.
  • 5Yah ZQ, Hansson GK. Innate immunity, macrophage acti- vation, and atherosclerosis[J]. Immunol Rev, 2007, 219(10): 187-203.
  • 6Michelsen KS, Doherty TM, Shah PK, et al. Role of Toll- like receptors in atherosclerosis [ J ]. Circ Res, 2004, 95 (12) : 96-97.
  • 7Methe H, Kim JO, Kofler S, et al. Expansion of circulat- ing Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome [ J ]. Circulation, 2005, 111 (20) : 2 654-661.
  • 8Chavez-Sanchez L, Madrid-Miller A, Chavez-Rueda K, et al. Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and mono- cytes triggers the inflammatory response [ J ]. Hum Immu- nol, 2010, 71(8) : 737-744.
  • 9Grenier D, Grignon L. Response of human macrophage-like cells to stimulation by Fusobaeterium nucleatum ssp. nu- cleatum lipopolysaceharide [ J ]. Oral Microbiol lmmunol, 2006, 21(3): 190-196.
  • 10den Dekker WK, Cheng C, Pasterkamp G, et al. Toll like receptor 4 in atherosclerosis mad plaque destabilization [ J ]. Atherosclerosis, 2010, 209(2): 314-320.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部